Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk
Kidney Int Rep
.
2023 May 16;8(8):1660-1664.
doi: 10.1016/j.ekir.2023.05.009.
eCollection 2023 Aug.
Authors
Sachin Naik
1
,
Deeksha Pal
1
,
Shubham Shukla
1
,
Vinod Kumar
2
,
Ashwini Kumar
3
,
Vivekanand Jha
4
5
6
,
Ranjana Minz
7
,
Jasmine Sethi
1
,
Joyita Bharati
1
,
Smita Divyaveer
1
,
Vivek Kumar
1
,
Manish Rathi
1
,
Harbir Singh Kohli
1
,
Raja Ramachandran
1
Affiliations
1
Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
2
Department of Dermatology, Venereology and Leprosy, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
3
Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
4
The George Institute for Global Health, New Delhi, India.
5
Manipal Academy of Higher Education, Manipal, Karnataka, India.
6
University of Oxford, Oxford, UK.
7
Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
PMID:
37547518
PMCID:
PMC10403650
DOI:
10.1016/j.ekir.2023.05.009
No abstract available